Physician profile
Kyle Lipton
NPI 1144292707
$3,367.29
in general payments reported to CMS, 2019-2025
14 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $400 · 2021: $495 · 2022: $410 · 2023: $826 · 2024: $503 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.61 |
| Education | $190.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,612.51 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $457.13 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $416.20 | 2023-2025 | Veozah |
| Pfizer INC. | $277.97 | 2023-2024 | |
| Duchesnay USA Incorporated | $141.29 | 2019 | |
| Boston Scientific Corporation | $140.90 | 2024 | Watchman Flx |
| Evofem Biosciences, INC. | $69.03 | 2020-2022 | |
| Therapeuticsmd, INC. | $57.53 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $49.33 | 2025 | |
| Amgen INC. | $43.44 | 2021 | |
| Shield Therapeutics INC | $33.49 | 2024 | |
| Hologic Sales and Service, LLC | $27.11 | 2020 | |
| Scynexis, INC. | $25.74 | 2022 | |
| Agile Therapeutics, INC. | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.